BIOCHINA 2026 will host the Global Clinical Development Forum, connecting leading contract research organizations (CROs) with pharmaceutical companies.

As drug development becomes increasingly global, pharma companies face growing challenges in conducting multi-center trials, navigating diverse regulatory environments, and achieving efficient, compliant submissions. In advanced areas such as cell and gene therapy, ensuring data consistency and adapting to regional regulations are critical for timely product launches.

The forum will highlight clinical development strategies across different markets and showcase China-based trials for international projects. Leading domestic and international CROs, including Emerald Clinical and Plusbio, have confirmed their participation. They will present their core services and success stories, providing pharma companies with one-stop collaboration solutions.

The Global Clinical Development Forum at BIOCHINA 2026 offers a unique opportunity to gain strategic insights, explore best practices, and establish direct collaborations with top CROs worldwide.